Earlier today, Johnson & Johnson Vision announced a definitive agreement to acquire TearScience, Inc.
Johnson & Johnson Vision will reportedly acquire TearScience through its surgical vision operating company, Abbott Medical Optics Inc., with the transaction expected to close by the end of the year.
TearScience is reportedly a medical device manufacturer dedicated to evaluating meibomian gland health and treating Meibomian Gland Dysfunction (MGD). According to Johnson & Johnson Vision, the acquisition of TearScience will provide strategic value to the company and help further expand its eye health portfolio of products, allowing them to provide a solution to its optometric and ophthalmic customers who serve dry eye patients.
Like what you read? Follow OptometryWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
Click here to read the full press release
Source: Johnson & Johnson Vision